Down Syndrome: Genes, Model Systems, and Progress towards Pharmacotherapies and Clinical Trials for Cognitive Deficits

Publisher： Karger

E-ISSN： 1424-859x|141|4|260-271

ISSN： 1424-8581

Source： Cytogenetic and Genome Research, Vol.141, Iss.4, 2013-08, pp. : 260-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genotyping in Clinical Trials: Towards a Principle of Informed Request

By Sass Hans-Martin  

The Journal of Medicine and Philosophy, Vol. 23, Iss. 3, 1998-07 ,pp. : 288-296

Oxford University Press

Access to resources Recommend Favorite

Clinical Trials in Irritable Bowel Syndrome: A Review

By  

Reviews on Recent Clinical Trials, Vol. 8, Iss. 1, 2013-03 ,pp. : 9-22

Bentham Science Publishers

Access to resources Recommend Favorite

Down syndrome and the genes of human chromosome 21: current knowledge and future potentials

By  

Cytogenetic and Genome Research, Vol. 121, Iss. 1, 2008-05 ,pp. : 67-77

Karger

Access to resources Recommend Favorite

Assessing benefit in trials: Are we making progress in assessing progression in cancer clinical trials?

By  

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1728-1730

John Wiley & Sons Inc

Access to resources Recommend Favorite

Towards a Professional Ethics Model of Clinical Ethics

By McCullough Laurence  

The Journal of Medicine and Philosophy, Vol. 32, Iss. 1, 2007-01 ,pp. : 1-6

Oxford University Press

Access to resources Recommend Favorite